Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
AmericaFirst Monthly Risk-On Risk-Off U ABRUX
- NAV / 1-Day Return 12.47 / +1.14 %
- Total Assets 4.6 Mil
-
Adj. Expense Ratio
- Expense Ratio 3.370%
- Distribution Fee Level —
- Share Class Type —
- Category Tactical Allocation
- Investment Style Large Growth
- Credit Quality / Interest Rate Sensitivity —
- Status Open
- TTM Yield —
- Turnover 326%
USD | NAV as of May 03, 2024 | 1-Day Return as of May 03, 2024, 10:14 PM GMT+0
Morningstar’s Analysis ABRUX
Will ABRUX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 43.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Cash & Cash Equivalents | 7.04 | 314,608 | Cash and Equivalents |
Novo Nordisk A/S ADR | 5.74 | 256,620 | Healthcare |
Eli Lilly and Co | 5.43 | 242,922 | Healthcare |
Monte Rosa Therapeutics Inc | 4.68 | 209,321 | Healthcare |
NVIDIA Corp | 4.48 | 200,453 | Technology |
DraftKings Inc Ordinary Shares - Class A | 4.23 | 188,890 | Consumer Cyclical |
Nu Holdings Ltd Ordinary Shares Class A | 4.02 | 179,798 | Financial Services |
Microsoft Corp | 3.89 | 174,031 | Technology |
TG Therapeutics Inc | 3.87 | 173,004 | Healthcare |
Amazon.com Inc | 3.66 | 163,800 | Consumer Cyclical |